Guidelines on processing and reporting of prostate biopsies: the 2013 update of the pathology committee of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
about
Transperineal ultrasound-guided 12-core prostate biopsy: an extended approach to diagnose transition zone prostate tumors.Length of prostate biopsies is not necessarily compromised by pooling multiple cores in one paraffin block: an observational studyPrognostic histopathological and molecular markers on prostate cancer needle-biopsies: a reviewPredictive criteria of insignificant prostate cancer: what is the correspondence of linear extent to percentage of cancer in a single core?Optimizing safety and accuracy of prostate biopsy.Longer biopsy cores do not increase prostate cancer detection rate: A large-scale cohort study refuting cut-off values indicated in the literatureRule-based versus probabilistic selection for active surveillance using three definitions of insignificant prostate cancer.Serum monocyte fraction of white blood cells is increased in patients with high Gleason score prostate cancer.A randomized trial of early detection of clinically significant prostate cancer (ProScreen): study design and rationale.The Significance of Accurate Determination of Gleason Score for Therapeutic Options and Prognosis of Prostate Cancer.Handling and reporting of transperineal template prostate biopsy in Europe: a web-based survey by the European Network of Uropathology (ENUP).Gleason underestimation is predicted by prostate biopsy core length.Variation in reporting of cancer extent and benign histology in prostate biopsies among European pathologists.Minimum 6 mm core length is strongly predictive for the presence of glandular tissue in transrectal prostate biopsy.
P2860
Q35106786-5BBC807E-5575-4CA2-BEDB-C00306E6996BQ35587112-69DC016A-8F2E-4BF7-9699-8A4EC1E695F2Q38253055-902D1A9A-98FB-4569-8448-A1F7B453EB5BQ38392314-1B8ACAEE-8630-409D-BB60-F35B0AA931B5Q38841864-8A9833B3-202F-4779-98B7-6D148CC9C74AQ41455679-EA84611B-34CC-4A30-9C54-496C79902713Q41599088-AF7CF32C-965C-4DCC-ABF8-6D9C5EAFB807Q42202612-0A74AB0E-22B1-4E17-8138-7835EE2F6855Q47759609-A5A83772-BD4A-4F1C-BC44-9495B4B4D88BQ48919141-F3787CFF-9A44-49FC-B553-A31C98055EDEQ50073783-00B9B484-0E85-4F6F-9B9F-39515D29BC2EQ50644343-6F0958E6-0006-45A3-A235-7ECDB04EEC0BQ53094230-3BBF8E5A-E221-4157-AB23-87D70351B2E2Q53581835-873F23EA-FDDE-4E99-98D1-722D0586992F
P2860
Guidelines on processing and reporting of prostate biopsies: the 2013 update of the pathology committee of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Guidelines on processing and r ...... g for Prostate Cancer (ERSPC).
@en
type
label
Guidelines on processing and r ...... g for Prostate Cancer (ERSPC).
@en
prefLabel
Guidelines on processing and r ...... g for Prostate Cancer (ERSPC).
@en
P2093
P2860
P1433
P1476
Guidelines on processing and r ...... ng for Prostate Cancer (ERSPC)
@en
P2093
C Mazerolles
G J Van Leenders
L Bubendorf
M R Raspollini
Pathology Committee of the Eur ...... ng for Prostate Cancer (ERSPC)
P2860
P2888
P304
P356
10.1007/S00428-013-1466-5
P577
2013-08-06T00:00:00Z